Physician

Trevor Clark Austin, MD

According to 2025 Medicare claims, Trevor Austin, MD (NPI: 1659509644) practices internal medicine in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 28806-2316. Austin is affiliated with the Mission Health Partners, LLC (ACO ID: A2591) and AdvantagePoint Health Alliance - Western North Carolina, LLC (ACO ID: A5039), participating under the MSSP model.

Austin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 862 traditional Medicare patients, billed 141,895 HCPCS/CPT codes, and received $2,913,386 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,273 prescription claims across 198 beneficiaries totaling $2,949,016 in drug costs, led by Revlimid (Lenalidomide). DME data shows 39 claims. Open Payments data shows 48 records totaling $1,077. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $615,727 to $2,913,386. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,570,073 to $2,949,016. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,479 to $225.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$2.9M2015 Medicare payment: $615,727 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $620,763 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $721,241 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $978,106 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $822,195 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,874,721 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,001,015 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,849,563 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,448,044 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,913,386 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201568744,739$615,727
201667148,953$620,763
201762346,125$721,241
201850656,403$978,106
201950255,271$822,195
2020782135,074$1,874,721
2021808131,541$2,001,015
2022823107,144$1,849,563
2023919125,896$2,448,044
2024862141,895$2,913,386

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$2.9M2015 Drug cost: $1,570,073 (USD; Tot_Drug_Cst)2016 Drug cost: $1,437,986 (USD; Tot_Drug_Cst)2017 Drug cost: $1,235,736 (USD; Tot_Drug_Cst)2018 Drug cost: $1,262,235 (USD; Tot_Drug_Cst)2019 Drug cost: $713,607 (USD; Tot_Drug_Cst)2020 Drug cost: $1,468,702 (USD; Tot_Drug_Cst)2021 Drug cost: $1,386,280 (USD; Tot_Drug_Cst)2022 Drug cost: $1,583,814 (USD; Tot_Drug_Cst)2023 Drug cost: $2,808,461 (USD; Tot_Drug_Cst)2024 Drug cost: $2,949,016 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015181908$1,570,073
20162021,072$1,437,986
2017196748$1,235,736
2018175725$1,262,235
2019166548$713,607
2020141569$1,468,702
2021172658$1,386,280
2022150638$1,583,814
2023188897$2,808,461
20241981,273$2,949,016

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$34K$69K2015 Medicare payment: $68,948 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $16,504 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $14,604 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $16,261 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $5,619 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $6,683 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $3,280 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $5,669 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,501 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R101$68,948
2016N/R52$16,504
2017N/R38$14,604
20183077$16,261
2019N/RN/RN/R
2020N/R59$5,619
20212490$6,683
2022N/R88$3,280
20231263$5,669
2024N/R39$1,501

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less162392$91
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more263450$88
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's216396$12
36415Insertion of needle into vein for collection of blood sample5461,083$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count5841,267$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide401,120$710,959
IbrancePalbociclib25700$396,372
XtandiEnzalutamide23690$298,869
CalquenceAcalabrutinib Maleate341,014$257,539
Abiraterone AcetateAbiraterone Acetate501,500$116,511

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A5057Ostomy pouch, drainable, with extended wear barrier attached, with built in convexity, with filter, (1 piece), eachNN/R11$924
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R17$320
J8521Capecitabine, oral, 500 mgNN/R11$256

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.48$1,077Takeda Pharmaceuticals U.S.A., Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Trevor Clark Austin, MD?

Tedicare shows public-source Medicare data for Trevor Clark Austin, MD (NPI 1659509644), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Trevor Clark Austin, MD have ACO affiliation data?

Trevor Clark Austin, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591) and AdvantagePoint Health Alliance - Western North Carolina, LLC (MSSP, ACO ID A5039).

What billing organization is linked to Trevor Clark Austin, MD?

Trevor Clark Austin, MD is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Trevor Clark Austin, MD have Open Payments data?

Trevor Clark Austin, MD has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.